U.S. Markets open in 4 hrs 50 mins
  • S&P Futures

    4,059.50
    -86.75 (-2.09%)
     
  • Dow Futures

    33,521.00
    -662.00 (-1.94%)
     
  • Nasdaq Futures

    13,000.50
    -345.50 (-2.59%)
     
  • Russell 2000 Futures

    2,134.20
    -69.10 (-3.14%)
     
  • Crude Oil

    63.78
    -2.30 (-3.48%)
     
  • Gold

    1,819.90
    -16.20 (-0.88%)
     
  • Silver

    27.10
    -0.56 (-2.03%)
     
  • EUR/USD

    1.2080
    -0.0072 (-0.5919%)
     
  • 10-Yr Bond

    1.6950
    +0.0710 (+4.37%)
     
  • Vix

    28.25
    +6.41 (+29.35%)
     
  • GBP/USD

    1.4057
    -0.0087 (-0.6171%)
     
  • USD/JPY

    109.6200
    +1.0000 (+0.9206%)
     
  • BTC-USD

    50,266.35
    -309.47 (-0.61%)
     
  • CMC Crypto 200

    1,468.19
    -95.64 (-6.12%)
     
  • FTSE 100

    7,004.63
    +56.64 (+0.82%)
     
  • Nikkei 225

    28,147.51
    -461.08 (-1.61%)
     

Facebook Converts Part Of Menlo Park Headquarters To Vaccination Site: Report

  • Oops!
    Something went wrong.
    Please try again later.
Anusuya Lahiri
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Facebook Inc (NASDAQ: FB) partnered with Ravenswood Family Health Centre to convert part of its Menlo Park, California, headquarters into a vaccination clinic for under-served communities, Bloomberg reports.

  • Facebook planned to arrange vaccine rides to and from Facebook’s campus. Facebook employees will be ineligible for the vaccination program.

  • Facebook partnered with the State of California and local non-profits to support mobile vaccination clinics in four of the state’s most affected regions.

  • This year, Facebook initiated a tool launch for vaccine-related information and added a COVID-19 information area to its photo-sharing site, Instagram.

  • Amazon.com Inc (NASDAQ: AMZN) planned to devote its Seattle, Washington campus to host pop-up clinics for vaccination in January.

  • Price action: FB shares traded lower by 0.14% at $311.66 on the last check Friday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.